On 06-June-2018, Carter Braxton Worth made the bullish technical case for J&J, the ginormous pharmaceutical and healthcare company. He pointed out that J&J has been trading like a consumer staple company, which as we all know has been quite weak for some time now. His thesis is that consumer staples are beginning to rally, so J&J was about to play catchup. On that day, JNJ was trading at $122.79. On Thursday, the stock traded as high as $128.21.
